HPV-type distribution in HPV-positive cervical cancer, subdivided into SCC/ASC, ADC and CIN 3, 2, 1 lesions.
| Type | Hierarchical attribution* | |||||||||||||
| Cancer | SCC/ASC | ADC | CIN3 | CIN2 | CIN1 | Total | ||||||||
| n | % | n | % | n | % | n | % | n | % | n | % | n | % | |
| hrHPV | ||||||||||||||
| 16 | 40 | 38.5 | 36 | 40.4 | 4 | 26.7 | 19 | 46.3 | 12 | 30.8 | 6 | 15.0 | 77 | 34.4 |
| 18 | 14 | 13.5 | 8 | 9.0 | 6 | 40.0 | 3 | 7.3 | 4 | 10.3 | 1 | 2.5 | 22 | 9.8 |
| 31 | 4 | 3.8 | 4 | 4.5 | 5 | 12.2 | 2 | 5.1 | 5 | 12.5 | 16 | 7.1 | ||
| 33 | 3 | 2.9 | 3 | 3.4 | 1 | 2.4 | 2 | 5.1 | 1 | 2.5 | 7 | 3.1 | ||
| 35 | 3 | 2.9 | 3 | 3.4 | 4 | 10.3 | 7 | 3.1 | ||||||
| 39 | 1 | 1.0 | 1 | 1.1 | 1 | 2.6 | 2 | 0.9 | ||||||
| 45 | 7 | 6.7 | 5 | 5.6 | 2 | 13.3 | 2 | 4.9 | 1 | 2.6 | 2 | 5.0 | 12 | 5.4 |
| 51 | 3 | 2.9 | 3 | 3.4 | 2 | 4.9 | 4 | 10.3 | 3 | 7.5 | 12 | 5.4 | ||
| 52 | 4 | 3.8 | 4 | 4.5 | 3 | 7.3 | 2 | 5.1 | 1 | 2.5 | 10 | 4.5 | ||
| 56 | 1 | 2.5 | 1 | 0.4 | ||||||||||
| 58 | 4 | 3.8 | 4 | 4.5 | 3 | 7.3 | 1 | 2.6 | 2 | 5.0 | 10 | 4.5 | ||
| 59 | 1 | 1.0 | 1 | 1.1 | 1 | 2.5 | 2 | 0.9 | ||||||
| 66 | 1 | 2.4 | 1 | 2.6 | 2 | 0.9 | ||||||||
| 68 | 2 | 1.9 | 2 | 2.2 | 1 | 2.5 | 3 | 1.3 | ||||||
| lrHPV | ||||||||||||||
| 6 | 1 | 2.6 | 2 | 5.0 | 3 | 1.3 | ||||||||
| 44 | ||||||||||||||
| 53 | 1 | 2.5 | 1 | 0.4 | ||||||||||
| 54 | ||||||||||||||
| 61 | 1 | 2.5 | 1 | 0.4 | ||||||||||
| 67 | 1 | 1.0 | 1 | 1.1 | 1 | 0.4 | ||||||||
| 70 | 2 | 5.0 | 2 | 0.9 | ||||||||||
| 71 | ||||||||||||||
| 74 | ||||||||||||||
| 82 | 1 | 1.0 | 1 | 1.1 | 1 | 0.4 | ||||||||
| 91 | ||||||||||||||
| X | 4 | 3.8 | 4 | 4.5 | 1 | 2.5 | 5 | 2.2 | ||||||
| Total | 92 | 88.5 | 80 | 89.9 | 12 | 80.0 | 39 | 95.1 | 35 | 89.7 | 31 | 77.5 | 197 | 87.9 |
| Negative | 12 | 11.5 | 9 | 10.1 | 3 | 20.% | 2 | 4.9 | 4 | 10.3 | 9 | 22.5 | 27 | 12.1 |
ADC, adenocarcinomae; ASC, adenosquamous carcinoma; CIN, cervical intraepithelial neoplasia; SCC, squamous cell carcinoma.